Skip to main content
placeholder image

In vitro and preclinical studies of targeted alpha therapy for human breast cancer using 213Bi-labeled-plasminogen activator inhibitor type 2

Conference Paper


Abstract


Publication Date


  • 2001

Citation


  • Allen, B. J., Tian, Z., Li, Y., Andronicos, N. J., Rizvi, S., & Ranson, M. (2001). In vitro and preclinical studies of targeted alpha therapy for human breast cancer using 213Bi-labeled-plasminogen activator inhibitor type 2. In EUROPEAN JOURNAL OF NUCLEAR MEDICINE Vol. 28 (pp. 1191). SPRINGER-VERLAG. Retrieved from http://gateway.webofknowledge.com/

Number Of Pages


  • 1

Start Page


  • 1191

End Page


  • 1191

Volume


  • 28

Issue


  • 8

Abstract


Publication Date


  • 2001

Citation


  • Allen, B. J., Tian, Z., Li, Y., Andronicos, N. J., Rizvi, S., & Ranson, M. (2001). In vitro and preclinical studies of targeted alpha therapy for human breast cancer using 213Bi-labeled-plasminogen activator inhibitor type 2. In EUROPEAN JOURNAL OF NUCLEAR MEDICINE Vol. 28 (pp. 1191). SPRINGER-VERLAG. Retrieved from http://gateway.webofknowledge.com/

Number Of Pages


  • 1

Start Page


  • 1191

End Page


  • 1191

Volume


  • 28

Issue


  • 8